LONDON (Reuters) – London’s High Court on Tuesday ruled that one of Moderna’s patents relating to technology key to the development of vaccines for COVID-19 was invalid, but that another was valid and had been infringed by Pfizer and BioNTech’s rival vaccine. Pfizer and its German partner BioNTech sued Moderna at London’s High Court in […]
It’s no secret why Pfizer (NYSE: PFE) stock has been struggling this year. Investors are worried about how well the company will be able to do in light of waning demand for its COVID-19 vaccine and pill. It’s also facing patent cliffs for many of its top drugs. That’s why even though it’s trading at […]
Moderna (MRNA) stock tumbled Wednesday after the company said its newly approved RSV vaccine was only about 50% effective after 18 months — paling in comparison to rivals from Pfizer (PFE) and GSK (GSK). ↑ X NOW PLAYING CRSP Stock On Wild Ride After FDA’s Historic Approval. These Gene Editing Treatments Could Come Next. Respiratory […]
When it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent names often come to mind: Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY). Both companies have a long history of paying dividends and offer attractive yields, making them popular choices among income-seeking investors. However, when comparing these two stocks, […]
By Brendan Pierson (Reuters) – The U.S. state of Kansas on Monday sued Pfizer, accusing the company of misleading the public about its COVID-19 vaccine by hiding risks while making false claims about its effectiveness. In a lawsuit filed in the District Court of Thomas County, the state said the New York-based drugmaker’s alleged false […]
The state of Kansas filed a lawsuit on Monday against pharmaceutical company Pfizer, alleging the company made “misleading claims” about the effectiveness of the COVID-19 vaccine and the risks associated with the shot. The suit, filed by Kansas Attorney General Kris Kobach (R) in the District Court of Thomas County, claims Pfizer misled Kansas residents […]
Pfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous session’s end. The stock trailed the S&P 500, which registered a daily gain of 0.85%. Meanwhile, the Dow lost 0.09%, and the Nasdaq, a tech-heavy index, added 1.53%. Coming into today, shares of the drugmaker had lost 1.23% in […]
Are Pfizer‘s (NYSE: PFE) best days behind it? If the stock’s critics are to be believed, the answer is an emphatic “yes, obviously,” with issues like its recent stint of unprofitability and a beaten-down top line being the primary pieces of supporting evidence. But even the best companies can sometimes have a few quarters of […]
Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Pfizer Inc. (NYSE:PFE) has long been a favorite among income investors, thanks to its generous dividend yield and history of consistent payouts. With a […]
A few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy after the company ended up with a highly successful product in Comirnaty. The uncertainty surrounding COVID and the potential for there to be a need for ongoing annual shots made investors bullish that the public […]
The pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (NYSE: PFE) benefitted a few years ago has trickled down to a small stream. As a result, share prices have fallen and the stock trades near its lowest level in years. The falling share price has pushed the stock’s dividend yield to nearly 6%. There are […]
Fool.com contributor Parkev Tatevosian reviews Pfizer (NYSE: PFE) stock for passive income investors. *Stock prices used were the afternoon prices of May 28, 2024. The video was published on May 30, 2024. Should you invest $1,000 in Pfizer right now? Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team […]